Sold as Thypinone, Thyrel Trh. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 2 applications for Protirelin (sold as Thypinone, Thyrel Trh), first approved Nov 5, 1976, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Nov 5, 1976 | ThypinoneNDA 17638 · New molecular entity | Abbott | 7 | Discontinued |
| Jul 18, 1978 | Thyrel TrhNDA 18087 · New formulation or manufacturer | Ferring | 10 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Abbott